Scientists reported that an AI-designed universal coronavirus vaccine successfully passed its first human clinical trial showing strong immune responses.
Tag: Vaccine
Personalized Vaccine Combined With Checkpoint Inhibitor Shows Strong Phase 2 Trial Results at ASCO
An mRNA-based personalized cancer vaccine combined with immune checkpoint therapy shows substantial tumor control in a Phase 2 clinical trial
Personalized Cancer Vaccine Intismeran Autogene Shows Promising Phase 2 Results at ASCO 2026
Phase 2 trial presented at ASCO annual conference shows that the personalized mRNA cancer vaccine intismeran autogene improves outcomes in solid tumors
New mRNA vaccine shows promise against skin cancer
Phase 2 trials demonstrate strong immune response against advanced melanoma.